Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer

Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer

Bibliographic Details
Main Authors: Sungpil Yoon, Xiaoju Wang, Sompong Vongpunsawad, Gerard Tromp, Helena Kuivaniemi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
drug repositioning
resistant cancer
P-gp overexpresssion
MDR
anticancer drug
molecular targeting
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.632657/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.632657/full

Similar Items